Back
Recursion Pharmaceuticals Vs. United Therapeutics Industry Stock Comparison
Sell
33
RXRX
Recursion Pharmaceuticals
Last Price:
$5.28
Seasonality Move:
-11.7%
Sell
47
UTHR
United Therapeutics
Last Price:
$297.69
Seasonality Move:
7.07%
Sell
33
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
-
The current Recursion Pharmaceuticals [RXRX] share price is $5.28. The Score for RXRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
-
The current United Therapeutics [UTHR] share price is $297.68. The Score for UTHR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $5.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight selling pressure.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $297.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.34 | Buy |
Relative Strength Index (14 RSI): | 52.45 | Buy |
Chaikin Money Flow: | -4084130 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.99 - 5.43) | Buy |
Bollinger Bands (100): | (4.21 - 7.03) | Sell |
UTHR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 73.48 | Buy |
Relative Strength Index (14 RSI): | 51.74 | Buy |
Chaikin Money Flow: | 197494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (281.03 - 304.31) | Buy |
Bollinger Bands (100): | (285.58 - 326.24) | Sell |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.33 | Sell |
20-day SMA: | 5.17 | Buy |
50-day SMA: | 4.85 | Buy |
200-day SMA: | 6.27 | Sell |
8-day EMA: | 3.87 | Buy |
20-day EMA: | 2.14 | Buy |
50-day EMA: | 0.99 | Buy |
200-day EMA: | 0.27 | Buy |
UTHR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 296.06 | Buy |
20-day SMA: | 290.93 | Buy |
50-day SMA: | 300.94 | Sell |
200-day SMA: | 335.38 | Sell |
8-day EMA: | 212.95 | Buy |
20-day EMA: | 117.21 | Buy |
50-day EMA: | 53.97 | Buy |
200-day EMA: | 14.52 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.66 per share, an increase this year of $2.59 per share, and an increase next year of $0.97 per share.
Recursion Pharmaceuticals Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |